EdgarLookup

CEL SCI CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CEL SCI CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
-37469.5%
Profit Margin
Net income ÷ revenue
-90.3%
Return on Assets
Net income ÷ assets
0.76x
Debt-to-Equity
Total liabilities ÷ equity
+326.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2014 Sep 30, 2014 $67.8K Dec 23, 2014
FY2014 Jun 30, 2014 $15.9K Dec 23, 2014
FY2014 Mar 31, 2014 $67.2K Dec 23, 2014
FY2014 Dec 31, 2013 $113.1K Dec 23, 2014
FY2014 Sep 30, 2013 $15.5K Dec 23, 2014
FY2014 Jun 30, 2013 $113.7K Dec 23, 2014
FY2014 Mar 31, 2013 $15.4K Dec 23, 2014
FY2014 Dec 31, 2012 $15.0K Dec 23, 2014
FY2013 Sep 30, 2012 $108.0K Dec 27, 2013
FY2013 Jun 30, 2012 $35.0K Dec 27, 2013

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 ($25.41M) Dec 29, 2025
FY2025 Sep 30, 2024 ($26.92M) Dec 29, 2025
FY2024 Sep 30, 2023 ($32.37M) Jan 13, 2025
FY2023 Sep 30, 2022 ($36.70M) Dec 21, 2023
FY2022 Sep 30, 2021 ($36.36M) Dec 27, 2022
FY2021 Sep 30, 2020 ($30.26M) Dec 21, 2021
FY2020 Sep 30, 2019 ($22.13M) Dec 29, 2020
FY2019 Sep 30, 2018 ($31.84M) Dec 23, 2019
FY2018 Sep 30, 2017 ($14.36M) Dec 19, 2018
FY2017 Sep 30, 2016 ($11.51M) Dec 29, 2017

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 ($24.81M) Dec 29, 2025
FY2025 Sep 30, 2024 ($26.35M) Dec 29, 2025
FY2024 Sep 30, 2023 ($31.48M) Jan 13, 2025
FY2023 Sep 30, 2022 ($36.06M) Dec 21, 2023
FY2022 Sep 30, 2021 ($36.19M) Dec 27, 2022
FY2021 Sep 30, 2020 ($28.99M) Dec 21, 2021
FY2020 Sep 30, 2019 ($20.20M) Dec 29, 2020
FY2019 Sep 30, 2018 ($16.77M) Dec 23, 2019
FY2018 Sep 30, 2017 ($21.41M) Dec 19, 2018
FY2017 Sep 30, 2016 ($23.65M) Dec 29, 2017

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $28.16M Dec 29, 2025
FY2025 Sep 30, 2024 $26.99M Dec 29, 2025
FY2024 Sep 30, 2023 $30.53M Jan 13, 2025
FY2023 Sep 30, 2022 $50.52M Dec 21, 2023
FY2022 Sep 30, 2021 $75.87M Dec 27, 2022
FY2021 Sep 30, 2020 $40.54M Dec 21, 2021
FY2020 Sep 30, 2019 $27.62M Dec 29, 2020
FY2019 Sep 30, 2018 $29.59M Dec 23, 2019
FY2018 Sep 30, 2017 $22.92M Dec 19, 2018
FY2017 Sep 30, 2016 $24.89M Dec 29, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $12.20M Dec 29, 2025
FY2025 Sep 30, 2024 $14.12M Dec 29, 2025
FY2024 Sep 30, 2023 $17.31M Jan 13, 2025
FY2023 Sep 30, 2022 $18.36M Dec 21, 2023
FY2022 Sep 30, 2021 $19.34M Dec 27, 2022
FY2021 Sep 30, 2020 $20.81M Dec 21, 2021
FY2020 Sep 30, 2019 $22.49M Dec 29, 2020
FY2019 Sep 30, 2018 $29.59M Dec 23, 2019
FY2018 Sep 30, 2017 $26.26M Dec 19, 2018
FY2017 Sep 30, 2016 $25.57M Dec 29, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $15.96M Dec 29, 2025
FY2025 Sep 30, 2024 $12.87M Dec 29, 2025
FY2025 Sep 30, 2023 $13.21M Dec 29, 2025
FY2024 Sep 30, 2022 $32.16M Jan 13, 2025
FY2023 Sep 30, 2021 $56.53M Dec 21, 2023
FY2022 Sep 30, 2020 $19.73M Dec 27, 2022
FY2021 Sep 30, 2019 $5.13M Dec 21, 2021
FY2020 Sep 30, 2018 $916 Dec 29, 2020
FY2019 Sep 30, 2017 ($3.34M) Dec 23, 2019
FY2018 Sep 30, 2016 ($679.2K) Dec 19, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2022 Sep 30, 2022 0 Dec 27, 2022
FY2022 Sep 30, 2021 0 Dec 27, 2022
FY2021 Sep 30, 2020 0 Dec 21, 2021
FY2019 Sep 30, 2019 0 Dec 23, 2019
FY2019 Sep 30, 2018 (1) Dec 23, 2019
FY2018 Sep 30, 2017 (1) Dec 19, 2018
FY2017 Sep 30, 2016 (2) Dec 29, 2017
FY2016 Sep 30, 2015 (2) Dec 11, 2017
FY2016 Jun 30, 2015 (1) Dec 11, 2017
FY2016 Mar 31, 2015 (4) Dec 11, 2017

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 (6) Dec 29, 2025
FY2025 Sep 30, 2024 (15) Dec 29, 2025
FY2024 Sep 30, 2023 0 Jan 13, 2025
FY2022 Sep 30, 2022 0 Dec 27, 2022
FY2022 Sep 30, 2021 0 Dec 27, 2022
FY2021 Sep 30, 2020 0 Dec 21, 2021
FY2019 Sep 30, 2019 0 Dec 23, 2019
FY2019 Sep 30, 2018 (1) Dec 23, 2019
FY2018 Sep 30, 2017 (1) Dec 19, 2018
FY2017 Sep 30, 2016 (2) Dec 29, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2022 Sep 30, 2022 $22.67M Dec 27, 2022
FY2022 Sep 30, 2021 $36.06M Dec 27, 2022
FY2021 Sep 30, 2020 $15.51M Dec 21, 2021
FY2021 Sep 30, 2019 $8.44M Dec 21, 2021
FY2020 Sep 30, 2018 $10.31M Dec 29, 2020
FY2019 Sep 30, 2017 $2.37M Dec 23, 2019
FY2018 Sep 30, 2016 $2.92M Dec 19, 2018
FY2017 Sep 30, 2015 $5.73M Dec 29, 2017
FY2016 Sep 30, 2014 $8.51M Dec 11, 2017
FY2016 Sep 30, 2013 $41.6K Dec 11, 2017